CHTR vs DNTH · P/E 11, rev $55.09B vs rev $6.2M
Charter Communications Inc (CHTR) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CHTR and DNTH stock pages for the full models.
Not investment advice.